Federal Register / Vol. 89, No. 22 / Thursday, February 1, 2024 / Notices 6527 

disseminates, communicates, and 

promotes information to protect 

communities from adverse health 

impacts from air pollution; and (15) 

coordinates asthma- and air qualityrelated activities throughout CDC. 

Lead Poisoning Prevention and 

Surveillance Branch (CNCD) (1) 

establishes, monitors, and evaluates 

goals and objectives for a national 

childhood lead poisoning prevention 

program and blood lead surveillance 

system for CDC; (2) develops and 

implements an integrated national 

program to eliminate childhood lead 

poisoning through partnerships with 

U.S. Department of Housing and Urban 

Development, U.S. Environmental 

Protection Agency, other federal 

agencies, and national organizations; (3) 

coordinates efforts of federal, state, 

local, tribal and territorial agencies that 

have programs related to childhood lead 

exposure and prevention to achieve 

national objectives and performance 

standards related to eliminating 

childhood lead poisoning; (4) supports 

state, local, tribal and territorial health 

agencies, and other stakeholders, in 

planning, developing, and 

implementing childhood lead poisoning 

prevention programs and blood lead 

surveillance systems; (5) collects, 

analyzes, and disseminates data on 

blood lead levels in U.S. children; (6) 

develops, conducts, and evaluates 

epidemiologic research on childhood 

lead poisoning including risk factors, 

geographic distribution, and trends; (7) 

works collaboratively across, NCEH, 

CDC and with external partners to build 

capacity for science, innovation, and 

translation research to accelerate 

progress towards national lead 

poisoning prevention goals; (8) develops 

and implements, in concert with other 

federal agencies, national organizations, 

and other appropriate groups, a training 

agenda for public health professionals 

related to childhood lead poisoning 

prevention and surveillance activities; 

(9) administers the CDC/NCEH Federal 

Advisory Committee relevant to lead 

poisoning prevention; and (10) 

coordinates lead poisoning prevention 

and surveillance activities through the 

Division, Center, and with other 

components of CDC and external 

stakeholders, as appropriate. 

Emerging Environmental Hazards and 

Health Effects Branch (CCNCE) (1) 

promotes public health protection from 

environmental hazards and exposures, 

as well as environmental health 

disasters—both natural and 

technological—through education, 

training, and information dissemination 

to the general public as well as the 

public health and clinician 

communities; (2) serves as the CDC lead 

to prepare for and respond to natural, 

nuclear/radiological, and chemical 

emergencies; (3) provides CDC 

leadership to protect public health and 

safety through independent oversight of 

the Army destruction mission including 

stockpiled weapons and recovered 

chemical weapons; (4) addresses 

environmental health emerging hazards 

by conducting surveillance, public 

health response, and environmental 

epidemiologic investigations and 

studies; (5) responds to outbreak or 

cluster investigations of non-infectious 

etiology; and (6) builds the 

environmental epidemiology capacity of 

domestic and international public 

health partners. 

Environmental Public Health 

Tracking Branch (CNCG) (1) develops 

and maintains the National 

Environmental Public Health Tracking 

Network, the cornerstone of the 

Environmental Public Health Tracking 

Program, which connects environmental 

and health data at the national, state, 

and local levels to drive innovative, 

cutting-edge programs and solutions 

that protect and improve the health of 

communities across the country; (2) 

collects, integrates, analyzes, and 

disseminates non-infectious disease, 

environmental, and sociodemographic 

data from a collective of partners at the 

national, state, and local levels; (3) 

delivers health, exposure, and hazards 

data, information summaries, and tools 

to enable analysis, visualization, and 

reporting of insights drawn from data; 

(4) provides timely, local, accessible 

information that drives actions to 

improve community health; and (5) 

empowers environmental and public 

health practitioners, healthcare 

providers, community members, policy 

makers, and others to make informationdriven decisions that affect their health. 

Delegations of Authority 

All delegations and redelegations of 

authority made to officials and 

employees of affected organizational 

components will continue in them or 

their successors pending further 

redelegation, provided they are 

consistent with this reorganization. 

(Authority: 44 U.S.C. 3101) 

Robin Bailey, Jr., 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2024–02018 Filed 1–31–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2024–1 Phase I and Phase II: Reagents for 

Immunologic Analysis of Non-mammalian 

and Underrepresented Mammalian Models 

(Topic 129). 

Date: February 26–29, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G56, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Poonam Tewary, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G56, Rockville, MD 

20852, (301) 761–7219, tewaryp@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 26, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–01954 Filed 1–31–24; 8:45 am] 

BILLING CODE 4140–01–P 


ddrumheller on DSK120RN23PROD with NOTICES1